• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Novo Nordisk A/S (NVO)

    -NYSE
    54.68 Up 0.84(1.56%) Mar 30, 4:03PM EDT
    Add to Portfolio
    Prev Close:53.84
    Open:53.81
    Bid:54.56 x 200
    Ask:64.00 x 200
    1y Target Est:75.00
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:53.72 - 54.95
    52wk Range:41.72 - 54.95
    Volume:3,508,139
    Avg Vol (3m):1,615,080
    Market Cap:142.15B
    P/E (ttm):37.27
    EPS (ttm):1.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVOUp 1.56%142.15B
    LLYUp 0.39%78.35B
    PFEUp 1.36%214.51B
    SNYUp 0.54%131.37B

    Key Statistics

    Forward P/E (1 yr):31.43
    P/S (ttm):11.01
    Ex-Dividend Date:21-Mar-14

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback